XJPX
4926
Market cap32mUSD
Oct 09, Last price
1,229.00JPY
1D
0.08%
1Q
-0.65%
Jan 2017
-48.64%
IPO
-13.57%
Name
C'Bon Cosmetics Co Ltd
Chart & performance
P/E
23.94
P/S
0.55
EPS
51.34
Div yield, %
1.63%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
0.36%
Revenues
9.27b
+4.84%
Net income
214m
+56.76%
CFO
763m
P
Dividend
Mar 30, 202710 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
C'BON COSMETICS Co.,Ltd. is engaged in the development and distribution of a diverse range of beauty products, encompassing conventional cosmetics, quasi-pharmaceuticals, and aesthetic devices. Its comprehensive product line includes essentials such as facial cleansers, lotions, moisturizing creams, washes, concentrated serums, and foundation primers. The company was established in 1966 and maintains its principal headquarters in Kawasaki, Japan.
Key people
Masahiro Inuzuka
Chairman of the Board, Representative Director · since 2021
Kazuhiro Sakiyama
President, Executive Officer, Representative Director · since 2021
Yuji Matsumoto
Executive Officer
Teruo Horizumi
Executive Officer, Director · since 2024
Keiko Sugawara
Executive Officer, Director · since 2021
Isao Iwata
Independent Director · since 2021
Haruko Osugi
Independent Director · since 2024
Independent Director · since 2024
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||